JAX Autoimmune Disease Mini-Symposium

|Share

Date: Tuesday, February 23, 2010
Location: South San Francisco Conference Center, San Francisco, CA (close to airport/free shuttle)
Time: Registration begins at 9:00am
How much: No charge, but seating is limited. Register today!
Contact: Cara.Wykowski@jax.org, 1-415-860-5998

This full day program will bring together scientists to discuss the use of animal models in drug discovery research. Presentations will cover preclinical models of autoimmune and inflammatory diseases such as inflammatory bowel disease, multiple sclerosis, and rheumatoid arthritis.

Confirmed Speakers

9:00-9:30am Arrival and coffee
9:30-9:45am

Yan Yang, Ph.D.
Business Unit Manager, JAX® In Vivo Services, The Jackson Laboratory

Opening Remarks

9:45-10:35am

Mandy J. McGeachy, Ph.D.
Senior Scientist, Immunology Discovery Research, Merck Research Laboratories, Palo Alto

Discovery of the Th17 Pathway: Insights from In Vivo Biology

10:40-11:30am

Martin Hegen, Ph. D.,
Principle Research Scientist II, Inflammation and Immunology, Pfizer

Utility of Animal Models for Identification of Potential Therapeutics for Rheumatoid Arthritis

11:35-12:30pm

Shomyseh Sanjabi, Ph.D.
Assistant Investigator, Gladstone Institute of Virology and Immunology, University of California, San Francisco

Animal Models for Studying the Role of TGF-β Signaling in T Cell Biology

12:30-1:30pm Lunch
1:30-2:20pm

F. Stephen Laroux, Ph.D.
Director, Immunology and Inflammatory Diseases, Cequent Pharmaceuticals, Inc.

Experimental Models of IBD: Utility in Preclinical Development

2:25-3:15pm

Oded Foreman, DVM Dip ACVP
Director of Pathology Service, The Jackson Laboratory

Methods for Quantitative Analysis of Pathological End Points in Mouse Models of Inflammatory Diseases

3:15-3:30pm

Leon Hall, Ph.D.
Program Director, JAX® In Vivo Core Services, The Jackson Laboratory

Follow Up Questions and Closing Remarks

Registration for this event is now closed.